NCT07610109 Effects of Comprehensive Community Support Programs on Cognitive Function and Quality of Life in Older Adults
| NCT ID | NCT07610109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Medipol University Hospital |
| Condition | Cognitive Decline |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2026-05-20 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to investigate the effects of a multidomain community-based support program on cognitive function and quality of life in older adults attending the Vefahane Life Center in Istanbul, Türkiye. The study will compare elderly individuals actively participating in community-based social, cognitive, physical, and supportive activities with individuals registered at the center but not actively participating during the study period. Participants will undergo neuropsychological and psychosocial assessments at baseline and after 3 months. The primary outcome is change in global cognitive performance measured by the Mini Mental State Examination (MMSE). Secondary outcomes include memory, executive functions, depression, neuropsychiatric symptoms, and quality of life measures.
Eligibility Criteria
Inclusion Criteria: * Elderly individuals aged 60 and over who attend or will attend Vefahane Life Center * Able to cooperate, * Individuals who speak Turkish * Individuals who are literate Exclusion Criteria: * Individuals previously diagnosed with dementia, * Individuals with neurological and psychiatric diagnoses that affect cognitive skills, * Individuals receiving occupational therapy interventions aimed at improving cognitive skills within the center, * Individuals with illnesses that prevent participation in the activity program (cancer, cardiovascular instability, etc.), * Individuals with severe visual and hearing loss that hinders communication.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07610109 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Cognitive Decline. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07610109 currently recruiting?
Yes, NCT07610109 is actively recruiting participants. Contact the research team at lhanoglu@kure.com.tr for enrollment information.
Where is the NCT07610109 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07610109 clinical trial?
NCT07610109 is sponsored by Istanbul Medipol University Hospital. The trial plans to enroll 120 participants.